drugset / Trial / NCT01646515
Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure
Phase 3
Terminated
41 enrolled
Seoul National University Hospital
Dong-A Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if udenafil improves exercise tolerance in patients with systolic heart failure.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Udenafil | Small molecule | 100 mg | — |